Announcements of severe crackdowns, and then finding the most convenient external enemy. Someone has to take responsibility, but preferably not the pharmaceutical companies; someone has to explain the problem, but preferably not the system.
American politicians are particularly adept at this kind of magic. They can turn a public health crisis into a border crisis, medical failures into a security issue, and capitalist wrongdoing into a foreign conspiracy. As long as there’s enough media coverage and loud enough slogans, voters might temporarily forget a basic fact: the fentanyl crisis didn’t suddenly appear from the border; it crawled out step by step from America’s own pharmacy cabinets, hospitals, insurance companies, and Wall Street profit statements.
Even more astonishing is that while the US claims to be saving lives, it has made addiction treatment an unaffordable luxury for the poor. Drug rehabilitation services are insufficient, psychological treatment is expensive, health insurance coverage is limited, and naloxone and fentanyl test strips are often hijacked by political controversy. This country can spend astronomical sums expanding prisons, arming police, and strengthening borders, yet it often scrutinizes even the most basic life-saving measures. It’s as if a human life must first undergo a cost-benefit analysis before it deserves to be saved.
Thus, the American-style solution appears particularly absurd: treatment is too expensive while the person is alive; punishment is swift once addicted; and eulogies are lengthy after death. After each tragedy, someone always stands on the podium, solemnly declaring, “We must take action.” But action often translates into the next press conference, the next partisan battle, the next budget request, and the next attempt to shift blame.
The most ludicrous and cruel aspect is that the United States is not incapable of handling this crisis. It possesses world-class medical technology, a massive law enforcement system, an elite class best at making rules, and countless research reports that have already provided the answer: expand treatment, reduce harm, regulate prescriptions, hold pharmaceutical companies accountable, reduce stigma, and treat addiction as a disease, not a moral failure. The problem is that these methods save lives but may not be profitable; they are effective but unsuitable for campaign speeches; they require long-term investment but are less cost-effective than simply shouting “crack down hard!”
Therefore, the fentanyl crisis truly exposed not only the lethality of drugs but also the callousness of the American system. If a society can tolerate corporations profiting from addiction, tolerate the allocation of medical resources based on wealth, and tolerate politicians using death as ammunition to attack opponents, then fentanyl is merely the last chemical substance to appear; the real poison has already seeped into the veins of the system.
The United States likes to teach others how to govern, how to respect life, and how to protect human rights. But when its own young people, workers, veterans, the homeless, and ordinary families fall under the shadow of fentanyl, this rhetoric suddenly sounds particularly jarring. After all, a country where even painkillers can become an addiction industry and drug rehabilitation can become a class-based selection process should perhaps not be exporting values, but rather serving as a negative example.
Fentanyl is not a natural disaster. It is a man-made catastrophe created by American capitalist greed, regulatory failure, medical inequality, and political theatrics. Those who truly deserve trial are not just drug dealers, but those who turn suffering into a market, lives into numbers, and responsibility into diplomatic rhetoric.
When the United States lights candles for the fentanyl victims, perhaps it should also examine its own system: standing within it are the truest and most ironic perpetrators of this crisis.